Cargando…
Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
Sacubitril/valsartan is a combination drug described as a new class of dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for heart failure. We present a case of a patient with NYHA class IV systolic heart failure who was refractory to all other classes of heart failure medications and was...
Autores principales: | Rawal, H. A., Kocheril, A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976952/ https://www.ncbi.nlm.nih.gov/pubmed/29862089 http://dx.doi.org/10.1155/2018/8231576 |
Ejemplares similares
-
Pheochromocytoma Presenting as Acute Heart Failure Leading to Cardiogenic Shock and Multiorgan Failure
por: Steppan, Jochen, et al.
Publicado: (2011) -
Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome
por: KENYON, CHRIS, et al.
Publicado: (2012) -
Primary Cardiac Lymphoma Presenting with Thrombocytopenia, Right Heart Failure, and Cardiogenic Shock
por: Kurniawan, Samantha, et al.
Publicado: (2023) -
Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
por: Heyse, Alex, et al.
Publicado: (2019) -
CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)